Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 72, 109621
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Hubei Province (ZRM S2017000551)
- Wuhan University (RMYD2018M74)
This publication has 30 references indexed in Scilit:
- Signal Transduction by Vascular Endothelial Growth Factor ReceptorsCold Spring Harbor Perspectives in Medicine, 2012
- A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection For HCC Conforming to the Milan CriteriaAnnals of Surgery, 2011
- Recent advances in the treatment of hepatocellular carcinomaCurrent Opinion in Gastroenterology, 2010
- A ncRNA Modulates Histone Modification and mRNA Induction in the Yeast GAL Gene ClusterMolecular Cell, 2008
- Solid tumor physiology and hypoxia-induced chemo/radio-resistance: Novel strategy for cancer therapy: Nitric oxide donor as a therapeutic enhancerNitric Oxide, 2008
- MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed PairingMolecular Cell, 2007
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Transcriptome classification of HCC is related to gene alterations and to new therapeutic targetsHepatology, 2006
- New therapies for hepatocellular carcinomaOncogene, 2006
- Unique microRNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell, 2006